Pemphigus Vulgaris

General Pemphigus Vulgaris Information - Provided by MedlinePlus.gov

Currently Enrolling ACE Pemphigus Vulgaris Clinical Trials

~ Use of Infliximab for the Treatment of Pemphigus Vulgaris (APV01) ~

     APV01 is currently enrolling subjects at four locations. Please contact your nearest site's principal investigator or clinical trial coordinator for more information.

• Duke University (Durham, NC): Dr. Russell Hall at 919.684.3110 or Deborah Hannah at 919.681.5797
• University of Pennsylvania (Philadelphia, PA): Dr. Victoria Werth at 215.662.2399 or Joyce Okawa at 215.898.0168
• University of Southern California (Los Angeles): Dr. David Woodley at 323.865.0983 or Gail Kudo at 323.865.3564
• University of Iowa (Iowa City): Dr. Janet Fairely at 319.356.3609 or Debra Brandt at 319.353.6439